Radha Krishnan
Executive Director, Head of Clinical Pathology MSD
Seminars
Tuesday 31st March 2026
Panel Discussion: Redefining Biomarker Discovery with AI: Integrating Multi-Omic & Image-Based Insights for Smarter Oncology Trials
3:30 pm
- What are the critical steps in designing end-to-end AI pipelines that integrate computational pathology, RNA-seq, and clinical metadata? And, how can AI teams define clear success metrics for model validation, accuracy, reproducibility, and clinical actionability?
- How will foundation models and generative AI redefine how we integrate histological and omic modalities?
- How can partnerships between pharma, AI technology providers, and academic pathology groups accelerate validation and adoption?
Tuesday 31st March 2026
Machine Learning & Multimodal Approaches in MASH & IBD
2:30 pm
- Identify novel clinical (histological and molecular) biomarkers associated with patients’ response to treatment and disease severity
- Key cellular /human interpretable features from the H&E images of baseline biopsy samples from UC and CD to characterise the inflammatory microenvironment with spatial contextualised single cell resolution and spatial colocalisation
- Unlocking quantitative insights and human interpretable features of the inflammatory microenvironment (IME) has the potential to reveal biomarkers for treatment selection
- Development of fibrosis detection models on MASH and IBD
